N-[(3S,4R)-3-hydroxytetrahydropyran-4-yl]-1-methyl-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyrrolo[2,3-b]pyridine-6-carboxamide

ID: ALA4248057

Chembl Id: CHEMBL4248057

PubChem CID: 145982857

Max Phase: Preclinical

Molecular Formula: C25H27N5O3

Molecular Weight: 445.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc(-c2ccc(Cc3cc(C(=O)N[C@@H]4CCOC[C@H]4O)nc4c3ccn4C)cc2)n1

Standard InChI:  InChI=1S/C25H27N5O3/c1-29-10-7-19-18(13-16-3-5-17(6-4-16)20-8-11-30(2)28-20)14-22(26-24(19)29)25(32)27-21-9-12-33-15-23(21)31/h3-8,10-11,14,21,23,31H,9,12-13,15H2,1-2H3,(H,27,32)/t21-,23-/m1/s1

Standard InChI Key:  NEPARMOYJQSFNQ-FYYLOGMGSA-N

Alternative Forms

  1. Parent:

    ALA4248057

    ---

Associated Targets(Human)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor M1 (3437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.52Molecular Weight (Monoisotopic): 445.2114AlogP: 2.44#Rotatable Bonds: 5
Polar Surface Area: 94.20Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.78CX Basic pKa: 2.22CX LogP: 2.73CX LogD: 2.73
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -0.70

References

1. Engers JL, Childress ES, Long MF, Capstick RA, Luscombe VB, Cho HP, Dickerson JW, Rook JM, Blobaum AL, Niswender CM, Engers DW, Conn PJ, Lindsley CW..  (2018)  VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events.,  (9): [PMID:30258541] [10.1021/acsmedchemlett.8b00261]

Source